• Co-Founder & President

Bonnie Segal, President and Co-Founder of Segal Trials, is a trailblazer in clinical research. For over 20 years, her leadership has expanded Segal Trials to six sites with 200+ employees, focusing on Psychiatry, Addiction, Women’s Health, Infectious Disease and the Center for Psychedelic Research. Bonnie champions clinical trial awareness and mental health destigmatization. She previously served on the NAMI local board and is currently part of the CISRP Advisory Board. A pioneer in psychedelic research, Segal Trials, under Bonnie’s guidance, ventured into studies with psychedelics and cannabinoids for mental health. Recently, she founded the Center for Psychedelic, positioning Segal Trials as a U.S. leader in psychedelic studies, including a groundbreaking LSD study. With her at the helm, Segal Trials has completed 1,000+ clinical trials, led to 57+ FDA-approved indications, and remains devoted to advancing medical science for future generations.